
A Guide To The Risks Of Investing In Tonix Pharmaceuticals Holding Corp (TNXP)
In a filing, Tonix Pharmaceuticals Holding Corp revealed its Director Taylor Carolyn E. acquired Company’s shares for reported $15061.0 on
In a filing, Tonix Pharmaceuticals Holding Corp revealed its Director Taylor Carolyn E. acquired Company’s shares for reported $15061.0 on
Tonix Pharmaceuticals Holding Corp’s recent filing unveils that its Director Taylor Carolyn E. acquired Company’s shares for reported $15061.0 on
Tonix Pharmaceuticals Holding Corp’s recently made public that its Director Taylor Carolyn E. acquired Company’s shares for reported $15061.0 on
Tonix Pharmaceuticals Holding Corp’s filing revealed that its Director Taylor Carolyn E. acquired Company’s shares for reported $15061.0 on Aug
Tonix Pharmaceuticals Holding Corp’s filing revealed that its Director Taylor Carolyn E. acquired Company’s shares for reported $15061.0 on Aug
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Tonix Pharmaceuticals Holding Corp revealed its Chief Executive Officer LEDERMAN SETH acquired Company’s shares for reported $86200.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Tonix Pharmaceuticals Holding Corp’s recent filing unveils that its Chief Executive Officer LEDERMAN SETH acquired Company’s shares for reported $86200.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Tonix Pharmaceuticals